Treatment for post-hemorrhagic ventricular dilatation: a multiple-treatment meta-analysis

Mahoney, Liam, Luyt, Karen, Harding, David and Odd, David ORCID: https://orcid.org/0000-0002-6416-4966 2020. Treatment for post-hemorrhagic ventricular dilatation: a multiple-treatment meta-analysis. Frontiers in Pediatrics 8 , 238. 10.3389/fped.2020.00238

Preview

PDF - Published Version Available under License Creative Commons Attribution Non-commercial No Derivatives. Download (1MB) | Preview

Abstract

Objective: To perform a systematic review and multiple-treatment meta-analysis for the treatment of premature infants with post-hemorrhagic ventricular dilatation (PHVD), to prevent death or long-term neuro-disability. Design/Method: Asystematicreviewwasperformedusing PubMed, EMBASE, andthe Cochrane Library. A free-word search was performed to identify likely relevant literature intervention trials of PHVD in preterm infants. Initially, network mapping was performed followed by performing a Bayesian random-effects model using the Markov chain Monte Carlo method. Areas under the cumulative ranking curve (SUCRA) were calculated as a measure of the probability that each intervention was likely to be the 1st, 2nd, 3rd, etc. best therapy. Primary outcome measure was death or moderate or severe neurodevelopmental outcome at or beyond 12 months of corrected age. Results: Ten different trials were identified, enrolling 700 individuals (449 for the primary outcome). Seven intervention categories were identified, and of the 15 possible pair comparisons, 6 have been studied directly. In the multiple-treatment meta-analysis, no comparison reached conventional levels of statistical significance. Drainage Irrigation and Fibrinolytic Therapy (DRIFT) had the highest probability of being the best treatment for the primary outcome (82.1%), followed by CSF removal (10.8%), conservative management (6.7%), and then diuretic therapy (0.4%). Conclusions: PHVD is a significant cause of death and disability in developed countries, yet few therapeutic options have so far been trialed. While new therapies are urgently needed for these infants, at present, NMA shows that DRIFT appears to be the most likely candidate to improve outcomes after sIVH. Keywords: premature birth, brain injury, preterm, intraventricular hemorrhage, post-hemorrhagic ventricular dilatation

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine
Publisher:	Frontiers Media
ISSN:	2296-2360
Date of First Compliant Deposit:	31 July 2020
Date of Acceptance:	20 April 2020
Last Modified:	13 May 2023 03:49
URI:	https://orca.cardiff.ac.uk/id/eprint/133892

Citation Data

Cited 7 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item